Immunobiology of high-grade serous ovarian cancer: lessons for clinical translation

Torre, L. A. et al. Ovarian cancer statistics, 2018. CA Cancer J. Clin. 68, 284–296 (2018).

PubMed  PubMed Central  Article  Google Scholar 

Narod, S. Can advanced-stage ovarian cancer be cured? Nat. Rev. Clin. Oncol. 13, 255–261 (2016).

CAS  PubMed  Article  Google Scholar 

Vaughan, S. et al. Rethinking ovarian cancer: recommendations for improving outcomes. Nat. Rev. Cancer 11, 719–725 (2011).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Zhang, L. et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N. Engl. J. Med. 348, 203–213 (2003).

CAS  PubMed  Article  Google Scholar 

Chen, D. S. & Mellman, I. Elements of cancer immunity and the cancer-immune set point. Nature 541, 321–330 (2017).

CAS  PubMed  Article  Google Scholar 

Ovarian Tumor Tissue Analysis, C. et al. Dose-response association of CD8+ tumor-infiltrating lymphocytes and survival time in high-grade serous ovarian cancer. JAMA Oncol. 3, e173290 (2017).

Article  Google Scholar 

Hwang, W. T., Adams, S. F., Tahirovic, E., Hagemann, I. S. & Coukos, G. Prognostic significance of tumor-infiltrating T cells in ovarian cancer: a meta-analysis. Gynecol. Oncol. 124, 192–198 (2012).

PubMed  Article  Google Scholar 

Fridman, W. H., Pages, F., Sautes-Fridman, C. & Galon, J. The immune contexture in human tumours: impact on clinical outcome. Nat. Rev. Cancer 12, 298–306 (2012).

CAS  PubMed  Article  Google Scholar 

Tothill, R. W. et al. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Clin. Cancer Res. 14, 5198–5208 (2008).

CAS  PubMed  Article  Google Scholar 

George, J. et al. Nonequivalent gene expression and copy number alterations in high-grade serous ovarian cancers with BRCA1 and BRCA2 mutations. Clin. Cancer Res. 19, 3474–3484 (2013).

CAS  PubMed  Article  Google Scholar 

The Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature 474, 609–615 (2011).

PubMed Central  Article  CAS  Google Scholar 

Verhaak, R. G. et al. Prognostically relevant gene signatures of high-grade serous ovarian carcinoma. J. Clin. Invest. 123, 517–525 (2013).

CAS  PubMed  Google Scholar 

Chen, G. M. et al. Consensus on molecular subtypes of high-grade serous ovarian carcinoma. Clin. Cancer Res. 24, 5037–5047 (2018).

PubMed  PubMed Central  Article  Google Scholar 

Hanker, L. C. et al. The impact of second to sixth line therapy on survival of relapsed ovarian cancer after primary taxane/platinum-based therapy. Ann. Oncol. 23, 2605–2612 (2012).

CAS  PubMed  Article  Google Scholar 

Bamias, A. et al. Bevacizumab with or after chemotherapy for platinum-resistant recurrent ovarian cancer: exploratory analyses of the AURELIA trial. Ann. Oncol. 28, 1842–1848 (2017).

CAS  PubMed  Article  Google Scholar 

Markman, M. The use of bevacizumab in the management of ovarian cancer: an argument for single-agent rather than combination therapy. Ann. Oncol. 22, viii69–viii71 (2011).

PubMed  Article  Google Scholar 

Hamanishi, J. et al. Safety and antitumor activity of anti-PD-1 antibody, nivolumab, in patients with platinum-resistant ovarian cancer. J. Clin. Oncol. 33, 4015–4022 (2015).

CAS  PubMed  Article  Google Scholar 

Matulonis, U. A. et al. Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study. Ann. Oncol. 30, 1080–1087 (2019).

CAS  PubMed  Article  Google Scholar 

Duraiswamy, J. et al. Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulation. Cancer Cell https://doi.org/10.1016/j.ccell.2021.10.008 (2021).

Article  PubMed  Google Scholar 

Hornburg, M. et al. Single-cell dissection of cellular components and interactions shaping the tumor immune phenotypes in ovarian cancer. Cancer Cell 39, 928–944 e926 (2021).

CAS  PubMed  Article  Google Scholar 

Olalekan, S., Xie, B., Back, R., Eckart, H. & Basu, A. Characterizing the tumor microenvironment of metastatic ovarian cancer by single-cell transcriptomics. Cell Rep. 35, 109165 (2021).

CAS  PubMed  Article  Google Scholar 

Simoni, Y. et al. Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates. Nature 557, 575–579 (2018).

CAS  PubMed  Article  Google Scholar 

Ye, Q. et al. CD137 accurately identifies and enriches for naturally occurring tumor-reactive T cells in tumor. Clin. Cancer Res. 20, 44–55 (2014).

CAS  PubMed  Article  Google Scholar 

Webb, J. R., Milne, K., Watson, P., Deleeuw, R. J. & Nelson, B. H. Tumor-infiltrating lymphocytes expressing the tissue resident memory marker CD103 are associated with increased survival in high-grade serous ovarian cancer. Clin. Cancer Res. 20, 434–444 (2014).

CAS  PubMed  Article  Google Scholar 

Webb, J. R., Milne, K. & Nelson, B. H. PD-1 and CD103 are widely coexpressed on prognostically favorable intraepithelial CD8 T cells in human ovarian cancer. Cancer Immunol. Res. 3, 926–935 (2015).

CAS  PubMed  Article  Google Scholar 

Eiva, M. A., Omran., D. K., Chacon, J. & Powell, D. J. Jr Systematic analysis of CD39, CD103, CD137 and PD-1 as biomarkers for naturally occurring tumor antigen-specific TILs. Preprint at bioRxiv https://doi.org/10.1101/2021.03.29.437255 (2021).

Article  Google Scholar 

Desbois, M. et al. Integrated digital pathology and transcriptome analysis identifies molecular mediators of T-cell exclusion in ovarian cancer. Nat. Commun. 11, 5583 (2020).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Anadon, C. M. et al. Ovarian cancer immunogenicity is governed by a narrow subset of progenitor tissue-resident memory T cells. Cancer Cell https://doi.org/10.1016/j.ccell.2022.03.008 (2022).

Article  PubMed  Google Scholar 

Zhang, A. W. et al. Interfaces of malignant and immunologic clonal dynamics in ovarian cancer. Cell 173, 1755–1769 e1722 (2018).

CAS  PubMed  Article  Google Scholar 

Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. Nature 500, 415–421 (2013).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Bobisse, S. et al. Sensitive and frequent identification of high avidity neo-epitope specific CD8+ T cells in immunotherapy-naive ovarian cancer. Nat. Commun. 9, 1092 (2018).

PubMed  PubMed Central  Article  CAS  Google Scholar 

Liu, S. et al. Efficient identification of neoantigen-specific T-cell responses in advanced human ovarian cancer. J. Immunother. Cancer 7, 156 (2019).

PubMed  PubMed Central  Article  Google Scholar 

D’Angelo, S. P. et al. Antitumor activity associated with prolonged persistence of adoptively transferred NY-ESO-1c259T cells in synovial sarcoma. Cancer Discov. 8, 944–957 (2018).

PubMed  PubMed Central  Article  CAS  Google Scholar 

Siddiqui, I. et al. Intratumoral Tcf1+ PD-1+ CD8+ T cells with stem-like properties promote tumor control in response to vaccination and checkpoint blockade immunotherapy. Immunity 50, 195–211 e110 (2019).

CAS  PubMed  Article  Google Scholar 

Miller, B. C. et al. Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade. Nat. Immunol. 20, 326–336 (2019).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Kroeger, D. R., Milne, K. & Nelson, B. H. Tumor-Infiltrating plasma cells are associated with tertiary lymphoid structures, cytolytic T-cell responses, and superior prognosis in ovarian cancer. Clin. Cancer Res. 22, 3005–3015 (2016).

CAS  PubMed  Article  Google Scholar 

Conejo-Garcia, J. R., Rutkowski, M. R. & Cubillos-Ruiz, J. R. State-of-the-art of regulatory dendritic cells in cancer. Pharmacol. Ther. 164, 97–104 (2016).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Cubillos-Ruiz, J. R. et al. ER stress sensor XBP1 controls anti-tumor immunity by disrupting dendritic cell homeostasis. Cell 161, 1527–1538 (2015).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Chopra, S. et al. IRE1alpha-XBP1 signaling in leukocytes controls prostaglandin biosynthesis and pain. Science https://doi.org/10.1126/science.aau6499 (2019).

Article  PubMed  Google Scholar 

留言 (0)

沒有登入
gif